When investors map the U.S. dental services landscape, almost every line drawn starts from the same point in Effingham, Illinois. Heartland Dental is the largest dental support organization (DSO) in the country by supported-office count, and it has held that position for the better part of two decades. For a private-equity buyer, a credit analyst, or a strategic acquirer, Heartland is less a single company to evaluate than a benchmark against which the rest of the sector is measured.
Market Intelligence
Dental Market Intelligence for Investors & Operators
The Molar Report tracks dental organizations, market expansion, competitive dynamics, and industry trends. Get our independent research as we publish it.
Overview
Heartland Dental provides non-clinical administrative support services — operations, technology, marketing, procurement, human resources, real estate, and revenue-cycle management — to a network of affiliated dental practices that retain clinical autonomy. This is the core of the DSO model: the dentist keeps clinical control and (in many structures) an ownership interest, while Heartland supplies the back office. The company describes itself plainly as "the largest Dental Support Organization in the country,"1 and independent industry rankings agree, placing it first by a wide margin.2
What makes Heartland investor-relevant is not just its size but its consistency. Founded in 1997 and majority-owned since 2018 by global investment firm KKR, it has compounded growth across multiple ownership cycles while keeping a single, recognizable operating playbook. For an investor, that combination — durable scale plus a repeatable affiliation engine — is the asset. The open questions are about leverage, margin, and how much runway remains in a sector that is consolidating quickly around a handful of national platforms. We distinguish company-reported figures from third-party estimates throughout, because in private-DSO analysis the gap between the two is often where the real diligence lives.
Company Snapshot
- Founded: 1997, by Dr. Rick Workman, who began with a single dental practice.1
- Headquarters: Effingham, Illinois.1
- Leadership: Dr. Rick Workman is Founder & Executive Chairman; Patrick Bauer is President & CEO; DeAnn McClain (with the company since 1997) is COO; Mark Greenstein is Chief Growth Officer.1
- Ownership: Majority-owned by KKR (NYSE: KKR), which acquired its stake in 2018; Ontario Teachers' Pension Plan (OTPP) retained a minority position, and company leadership holds equity.1
- Scale: More than 1,900 supported offices and over 3,100 supported doctors across 39 states plus the District of Columbia (company-reported).1
- Clinical volume: Approximately 11.5 million patient visits in 2025 (company-reported).1
- Workforce: Roughly 25,000 team members across the corporate and supported-office network (company-reported; this figure varies by source — see Footprint Analysis).1
Footprint Analysis
Heartland's headline number is "1,900+" supported offices, and it is worth being precise about what that means and how confident an investor can be in it.
The company's own 2025 disclosures show a clear progression. In its "Strong First Half of 2025" release, Heartland stated it supported "over 3,000 doctors across more than 1,800 dental offices in 39 states and the District of Columbia." After closing a key affiliation with Smile Design Dentistry in September 2025, it reported "over 3,100 doctors in more than 1,880 locations." The year-end 2025 recap then put the network at "more than 1,900 supported practices" across 39 states plus DC (all company-reported).1 Independent rankings adopt the same figure: a 2026 industry ranking cites "1,900+" offices across "39 + DC," drawn from Heartland's corporate site.2
Two honesty notes for the diligence file. First, these are rounded "more than" minimums, not audited point-in-time counts; Heartland uses "over" and "+" language deliberately, so the true number drifts upward between disclosures. Second, sources disagree at the margins. A May 2026 PE roll-up tracker lists Heartland at roughly 2,500 supported offices — materially above the consensus 1,900+, and treated here as an unverified outlier rather than the headline.3 The most defensible read is "comfortably north of 1,900 and growing," with anything approaching 2,500 unverified against company disclosures.
On geography, the footprint spans 39 states and DC, though the company itself has occasionally cited "38" in 2026 materials — a minor internal inconsistency most plausibly explained by copy lag rather than a market exit.4 Third-party commentary describes concentration in the Midwest and Southeast.3 The first-half-2025 "footprint growth program" named expansion in Nevada, Florida, Texas, Utah, Colorado, Tennessee, Massachusetts, Georgia, North Carolina, Virginia, South Carolina, Oregon, Michigan, and Arizona1 — a deliberately diversified spread into Sun Belt and high-growth markets, which reads as densification of an already-national network rather than a land grab into new states.
Growth History
Heartland's trajectory is a textbook private-equity compounding story, and the milestones are well documented. The company supported roughly 800 offices across 34 states in 2017.2 At the close of 2017 — just before the KKR deal — supported-practice annual revenues were estimated at about $1.3 billion, reportedly a 126% increase over the five years of OTPP's prior majority ownership.5
The defining transaction came in 2018, when KKR acquired a majority interest from Ontario Teachers' Pension Plan and other shareholders, with OTPP retaining a minority stake (company-reported).1 A widely cited third-party analysis pegs the deal at roughly 58% control for an estimated $2.8 billion, leaving founder Dr. Workman with about a 10% stake valued near $170 million — but these specific percentages and dollar figures are single-source estimates and should be hedged accordingly.3 Notably, KKR made the investment through its longer-hold Core Investments strategy rather than a traditional buyout fund5 — a structural detail that signals patient capital and helps explain Heartland's steady, non-flip cadence.
Growth has since been a blend of de novo construction and affiliation. The company reports opening 105 offices in 2024.3 For 2025, Heartland reported adding 165 practices: 75 de novo, 33 through affiliation, and 60 via the acquisition of Smile Design Dentistry (company-reported).1 That mix — roughly half built from scratch, half acquired — is a meaningful tell for investors: a platform that can grow organically is less dependent on ever-rising acquisition multiples than a pure roll-up. Earlier affiliations include American Dental Partners (ADPI), which Heartland marked as a five-year milestone in mid-2026.1
Underlying Data
Need the data behind this analysis?
The Molar Report maintains structured datasets on the U.S. dental market. Request access for diligence or modeling.
- Practice location datasets
- DSO footprint tracking
- Geographic concentration analysis
- Market demographics
- Competitive landscape mapping
- Growth history
Business Model
The economics of a DSO like Heartland rest on the recurring nature of dental revenue. Industry analysis describes a typical mature general practice running 50–65% of revenue through commercial insurance contracts, 30–40% through recurring recall-hygiene visits, and the remainder through one-time procedures.3 That subscription-like cash flow is why PE buyers reportedly value dental platforms at 6–9x EBITDA at scale, versus 3–5x for less-recurring healthcare services — a stated sector range, not a Heartland-specific multiple.3
Heartland captures value by centralizing the non-clinical functions that individual practices struggle to optimize: procurement (one market analysis credits national DSOs with negotiating 15–20% supply discounts versus independents), HR, marketing, IT, and revenue cycle.3 A distinguishing feature, per its technology partners, is that Heartland keeps more of these processes — billing, scheduling, payments — inside the local practice supported by an embedded business associate, rather than fully centralizing them into a remote back office.6 For investors, that is a double-edged design: it may protect the local patient relationship and clinician satisfaction, but it can also limit the scale efficiencies a fully centralized operator might extract.
On revenue, the figures depend entirely on definition, and an investor should not conflate them. Heartland's supported network generated "more than $4.2 billion in total annual revenue" in 2025 — i.e., the patient-billings of the affiliated practices (company-reported).1 That is a different number from Heartland's own corporate/management-services revenue, which one credit-oriented source estimated at roughly $2.0 billion for FY2024.3 A roll-up tracker splits the difference at "~$3B+ system revenue."3 The honest takeaway: network revenue is comfortably in the multi-billion range and growing, but the precise figure that matters for valuation — Heartland's own take-rate revenue and EBITDA — is not publicly disclosed and should be treated as unknown. As a KKR-owned private company, Heartland has no public ticker or standalone credit rating; analysts often proxy sponsor strength through KKR & Co. itself.1
Technology & Software Ecosystem
Heartland's technology stack, based entirely on public and partner disclosures, centers on the Henry Schein One Dentrix family. Henry Schein One describes Heartland as operating "the world's largest deployment of Dentrix" — a vendor characterization.6 Public references point to Dentrix Enterprise as the practice-management backbone, with a stated direction toward cloud-based Dentrix Ascend and Henry Schein One's Unified Data Platform.
On clinical AI, Heartland announced VideaHealth as its preferred dental AI partner in December 2023, integrating VideaHealth's diagnostic AI (delivered as Dentrix Detect AI) into Dentrix and Dentrix Ascend — a deployment its partners characterize as among the largest dental-AI rollouts to date (partner superlatives hedged).1 Other named platforms include Dentira for procurement and lab management and HDflex for flexible staffing, with a broadly cloud-first orientation that public sources tie to Google Cloud Platform.4
One investor-relevant clarification: there is no public evidence that Heartland uses Epic as a core practice-management system. Epic integration is the differentiator claimed by competitor PDS Health, not Heartland.2 Heartland's bet is a deep, standardized Dentrix-plus-AI stack rather than a health-system EHR.
Competitive Landscape
Heartland sits at the top of a tightening peer set, and the comparison is the most useful frame for an investor. By supported-office count in late 2025/2026:2
- Heartland Dental — 1,900+ offices, 39 + DC, KKR-owned. The scale leader.
- Aspen Dental (The Aspen Group) — 1,100+ offices, multi-brand (Aspen, ClearChoice, plus non-dental WellNow Urgent Care), owned by Leonard Green & Ares.
- PDS Health — 1,000+ offices across ~25 states, the largest dentist-owned DSO, known for full Epic EHR integration.
- MB2 Dental — 800+ offices, a doctor-partnership model that emphasizes clinician equity, backed by Warburg Pincus and Charlesbank.
- Smile Brands — 600+ offices across 29 states under 75+ affiliated brands, owned by Gryphon Investors.
The top five DSOs collectively support more than 5,600 practices, and the top ten roughly 7,800.2 Heartland alone accounts for a substantial share of that base. What differentiates it from the field is breadth-plus-depth: Aspen is multi-vertical, PDS is dentist-owned and EHR-centric, MB2 leans into doctor ownership, and Smile Brands runs a multi-brand house — while Heartland pursues a single, standardized national support platform at the largest scale. Each model carries different margin and retention dynamics; Heartland's is the most "platform-pure," which is both its strength (repeatability) and its watch-item (less differentiation if a peer out-executes on clinician economics). For the full set, see our company profiles hub.
Market Position
Heartland's strategic position is strong and, for now, defensible. DSO affiliation reached roughly 13% of all U.S. practices by 2024, and investment continues to flow into the category.3 In a fragmented market still dominated by independents, the largest, best-capitalized consolidator with a proven dual de-novo-and-affiliation engine is well placed to keep compounding. KKR's long-hold Core Investments structure further reduces the pressure for a forced near-term exit, which historically has translated into steadier operations.
The constructive watch-items are the ones any investor in a leveraged, PE-owned platform should weigh — and they are limitations to monitor, not flaws. One credit-oriented source frames Heartland as "too large and too essential to fail operationally, yet too leveraged to achieve investment grade."3 The absence of disclosed corporate EBITDA and take-rate revenue means valuation rests partly on inference. And the sector's premium acquisition multiples mean future affiliation growth gets more expensive — which is precisely why Heartland's heavy de novo program (75 built in 2025) is a genuine competitive advantage rather than a footnote. None of these undercut the franchise; they simply define where the diligence work concentrates.
TMR Take: For operators, Heartland is the reference point — its embedded-business-associate model and Dentrix-plus-VideaHealth stack show how the largest platform balances standardization with local autonomy, and any practice weighing affiliation should benchmark suitors against it. For vendors, Heartland is the single most consequential enterprise account in dentistry; winning it (as Henry Schein One and VideaHealth have) is category-defining, but its keep-it-in-the-practice philosophy rewards tools that strengthen the local workflow over those that centralize it. For investors, the franchise is real — durable #1 scale, patient KKR capital, and a balanced organic/acquisitive growth engine — but the numbers that matter most (corporate EBITDA, take-rate revenue, leverage) are undisclosed, so treat the publicly stated $4.2B network revenue as a top-line proxy, not a valuation input, and weight the de novo capability heavily as multiples in the sector keep climbing.
Sources
-
Heartland Dental — company website, press releases, year-end recaps, and investor materials.
-
Industry DSO rankings — Medix Dental, Becker's Dental Review, and DrBicuspid.
-
Third-party market and financial analysis — Mordor Intelligence, CT Acquisitions, InvestmentGrade.com, and PitchBook.
-
The Molar Report analysis.
-
Industry and trade reporting — Group Dentistry Now.
-
Technology partners — Henry Schein One and VideaHealth.



